tiprankstipranks
AptarGroup (ATR)
NYSE:ATR
Holding ATR?
Track your performance easily

AptarGroup (ATR) Earnings Date & Reports

149 Followers

Earnings Data

Report Date
Feb 13, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
$1.27
Last Year’s EPS
$1.21
Same Quarter Last Year
Based on 5 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Oct 24, 2024
|
% Change Since: -5.03%
|
Next Earnings Date:Feb 13, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixture of positive outcomes and challenges. While the company showed solid growth in core sales and strong performance in the Pharma and Closures segments, the Beauty segment faced declines, and challenges persisted in the Chinese market. Overall, the company's strategic developments and recognition indicate a strong position moving forward.
Company Guidance
During Aptar's Q3 2024 earnings call, several key metrics were highlighted. The company reported core sales growth of 2% and an adjusted EPS of $1.49 per share, marking a 6% increase from the prior year's quarter. Year-to-date, adjusted EPS grew by 15%, positioning Aptar to achieve double-digit EPS growth for the full year. The company's adjusted EBITDA margin reached 23%, the upper end of their long-term range. Segment-wise, Pharma achieved 12% core sales growth, with an adjusted EBITDA margin of 36%, while Closures recorded 4% core sales growth and a 17% adjusted EBITDA margin. Beauty, however, faced a 6% decline in core sales but improved its adjusted EBITDA margin to 13%. Looking ahead, Aptar anticipates fourth-quarter adjusted EPS to range between $1.22 and $1.30, contributing to a full-year adjusted EPS range of $5.34 to $5.42. The company maintains a strong balance sheet with a leverage ratio of 1.1, allowing for strategic investments and shareholder returns.
Core Sales Growth
Aptar achieved core sales growth of 2% and adjusted EPS of $1.49 per share, a 6% increase over the prior year's quarter. Adjusted EPS grew by 15% for the first 9 months of the year.
Pharma Segment Performance
Pharma segment reported 12% core sales growth, driven by strong demand for proprietary drug delivery systems. Adjusted EBITDA margins were at the high end of the long-term target range.
Closure Segment Recovery
Closures segment returned to its core sales long-term target range with 4% growth and improved adjusted EBITDA margins of 17%, driven by increased demand and cost reduction efforts.
Significant Developments in Pharma
FDA approval for nasally delivered emergency medicine neffy and acquisition of SipNose's technology assets for intranasal delivery platforms.
Recognition and Innovations
Time named Aptar among World's Best Companies of 2024. Introduced multiple new products and received a contract from the U.S. government for ActivShield sterilization technology.
---

AptarGroup (ATR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ATR Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 13, 20252024 (Q4)
1.27 / -
1.21
Oct 24, 20242024 (Q3)
1.42 / 1.49
1.397.19% (+0.10)
Jul 25, 20242024 (Q2)
1.36 / 1.37
1.2311.38% (+0.14)
Apr 25, 20242024 (Q1)
1.15 / 1.26
0.9532.63% (+0.31)
Feb 08, 20242023 (Q4)
1.12 / 1.21
0.9231.52% (+0.29)
Oct 25, 20232023 (Q3)
1.27 / 1.39
0.9546.32% (+0.44)
Jul 27, 20232023 (Q2)
1.14 / 1.23
0.9628.13% (+0.27)
Apr 27, 20232023 (Q1)
0.90 / 0.95
0.96-1.04% (-0.01)
Feb 16, 20232022 (Q4)
0.79 / 0.92
0.93-1.08% (-0.01)
Oct 27, 20222022 (Q3)
0.94 / 0.95
0.941.06% (+0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

ATR Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 24, 2024$166.55$168.91+1.42%
Jul 25, 2024$141.11$146.27+3.66%
Apr 25, 2024$139.37$142.50+2.25%
Feb 08, 2024$130.97$137.75+5.18%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does AptarGroup (ATR) report earnings?
AptarGroup (ATR) is schdueled to report earning on Feb 13, 2025, TBA Not Confirmed.
    What is AptarGroup (ATR) earnings time?
    AptarGroup (ATR) earnings time is at Feb 13, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ATR EPS forecast?
          ATR EPS forecast for the fiscal quarter 2024 (Q4) is $1.27.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis